Sponsor

University of Campania Luigi Vanvitelli

Clinical research sponsor

Published trials85
Recruiting shown2
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early DementiaNCT06668610 · lead sponsor · 2024-10-01
RECRUITING
Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic PatientsNCT03463564 · lead sponsor · 2016-01-01
RECRUITING
Real-World Evaluation of TouchCare Nano in Pediatric Type 1 DiabetesNCT07425912 · lead sponsor · 2025-09-05
COMPLETED
The Brain&Senses StudyNCT06991816 · lead sponsor · 2025-08-01
ACTIVE_NOT_RECRUITING
DNA Methylation Trajectories in AgingNCT06582992 · lead sponsor · 2024-11-01
UNKNOWN
Psychoeducational Intervention for Families With a Member Affected by Major DepressionNCT05988333 · lead sponsor · 2023-09-27
UNKNOWN
Characterization of the "Transfusion-dependent Prediabetes" Using Continuous Glucose MonitoringNCT06533618 · lead sponsor · 2023-07-01
COMPLETED
Environmental Pollutants in COPD and Lung CancerNCT06483490 · lead sponsor · 2023-05-01
UNKNOWN
Evaluation of the Glucose Metrics After Eating Pizza Margherita in Hybrid Closed Loop UsersNCT05729776 · lead sponsor · 2022-12-01
COMPLETED
MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGINGNCT05623241 · lead sponsor · 2022-09-12
UNKNOWN
Breast Cancer, Omics, and Precision MedicineNCT04996836 · lead sponsor · 2022-01-01
UNKNOWN
Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)NCT05475028 · lead sponsor · 2021-09-14
COMPLETED
Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.NCT05125458 · lead sponsor · 2021-04-01
COMPLETED
Liraglutide and Peripheral Artery DiseaseNCT04881110 · lead sponsor · 2021-02-01
COMPLETED
Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With SchizophreniaNCT05130853 · lead sponsor · 2021-01-10
COMPLETED
Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually NearNCT04407663 · lead sponsor · 2020-03-03
COMPLETED
Stapler-less Burst Pressure in a Ex-vivo Human Gastric TissueNCT04488042 · lead sponsor · 2020-01-01
COMPLETED
Endometrial Malignancy in Breast Cancer Patients With or Without AUBNCT05977829 · lead sponsor · 2020-01-01
COMPLETED
Network Medicine, Epigenetics and ObesityNCT03903757 · lead sponsor · 2019-12-01
UNKNOWN
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)NCT04196231 · lead sponsor · 2019-11-27
COMPLETED
DNA Methylation Dynamics Underlying Arterial Remodeling in PAH Patients: CLEOPAHTRA Clinical TrialNCT04282434 · lead sponsor · 2019-06-14
COMPLETED
NIV Prevents Post-operative Respiratory Failure After Bariatric SurgeryNCT04830475 · lead sponsor · 2019-01-01
COMPLETED
Correlation Between Exercise and Insulin Dose in a Camp for Pediatric Type 1 PatientsNCT03725657 · lead sponsor · 2018-10-29
COMPLETED
High Salt Intake Unrelated to Obesity in DiabetesNCT04256447 · lead sponsor · 2018-05-02
COMPLETED
Management of Glycemia Following a Pizza MealNCT03748251 · lead sponsor · 2018-02-14
COMPLETED
Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)NCT03918148 · lead sponsor · 2018-01-15
COMPLETED
SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.NCT03366181 · lead sponsor · 2017-11-01
COMPLETED
Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non DiabeticsNCT03360981 · lead sponsor · 2017-09-20
COMPLETED
SGLT2i and Incretin and CRTd.NCT03282136 · lead sponsor · 2017-09-01
COMPLETED
STEMI and Incretins TreatmentNCT03312179 · lead sponsor · 2017-01-01
COMPLETED
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.NCT06017544 · lead sponsor · 2017-01-01
COMPLETED
Inflammatory Axis and Sirtuins' in Overweight Pre-diabetics PatientsNCT03491241 · lead sponsor · 2017-01-01
COMPLETED
Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart PatientsNCT03977116 · lead sponsor · 2017-01-01
COMPLETED
Analysis of the Microbiota and STEMINCT03439592 · lead sponsor · 2016-01-01
COMPLETED
Ghrelin and Diastolic Heart FunctionNCT05988346 · lead sponsor · 2016-01-01
COMPLETED
Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's DiseaseNCT02588924 · lead sponsor · 2015-09-01
UNKNOWN
Prediabetes and Non Obstructive Coronary Atherosclerosis.NCT03553030 · lead sponsor · 2015-01-01
COMPLETED
Molecular Mechanisms and Carotid AtherosclerosisNCT03962686 · lead sponsor · 2015-01-01
COMPLETED
CRTd Responders OptimizationNCT04547244 · lead sponsor · 2015-01-01
COMPLETED
To Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic ChildrenNCT02734446 · lead sponsor · 2014-04-01
COMPLETED
Factors Influencing Social Functioning of People With SchizophreniaNCT02166918 · lead sponsor · 2013-06-01
COMPLETED
Hyperglycemia in Patients With Takotsubo SyndromeNCT04684004 · lead sponsor · 2013-01-01
COMPLETED
Atrial Fibrillation AblationNCT03410966 · lead sponsor · 2013-01-01
COMPLETED
Sodium Intake in Failing Heart Patients.NCT03998891 · lead sponsor · 2013-01-01
COMPLETED
DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 DiabetesNCT01472432 · lead sponsor · 2011-05-01
COMPLETED
RAAS Inhibitor Drugs in Dialysis PatientsNCT01635387 · lead sponsor · 2010-02-01
UNKNOWN
Diabetes and Lipid Accumulationand Heart TransplantNCT03546062 · lead sponsor · 2010-01-01
COMPLETED
Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of IvabradineNCT01373619 · lead sponsor · 2010-01-01
COMPLETED
Stem Cells Therapy in Advanced Heart FailureNCT02871466 · lead sponsor · 2010-01-01
UNKNOWN
Ivabradine in Hemodialysed Patients With Increased Heart RateNCT01364077 · lead sponsor · 2010-01-01
UNKNOWN
Cardiac Autonomic Dysfunction in Diabetics Patients With SyncopeNCT03717207 · lead sponsor · 2010-01-01
COMPLETED
Aliskiren or Amlodipine in Hypertensive Hemodialysed PatientsNCT01394770 · lead sponsor · 2009-09-01
UNKNOWN
Pioglitazone Versus Metformin in Type 2 DiabetesNCT00815399 · lead sponsor · 2007-10-01
COMPLETED
Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 DiabetesNCT00641407 · lead sponsor · 2007-01-01
COMPLETED
Glycemic Durability After Metformin FailureNCT02142309 · lead sponsor · 2005-10-01
UNKNOWN
Nephropathy In Type 2 Diabetes and Cardio-renal EventsNCT00535925 · lead sponsor · 2005-10-01
COMPLETED
Loop Diuretics in Chronic Kidney DiseaseNCT00478543 · lead sponsor · 2005-09-01
COMPLETED
Dietary Control of Type 2 Diabetes: Low-Carbohydrate Mediterranean Diet Versus Low-Fat DietNCT00725257 · lead sponsor · 2004-06-01
COMPLETED
Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men: a Randomized Controlled TrialNCT00636688 · lead sponsor · 2000-10-01
COMPLETED
Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese WomenNCT00666874 · lead sponsor · 1999-02-01
COMPLETED

Sponsor roles

lead sponsor62
collaborator23

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.